162 related articles for article (PubMed ID: 28069692)
1. Genes involved in development and differentiation are commonly methylated in cancers derived from multiple organs: a single-institutional methylome analysis using 1007 tissue specimens.
Ohara K; Arai E; Takahashi Y; Ito N; Shibuya A; Tsuta K; Kushima R; Tsuda H; Ojima H; Fujimoto H; Watanabe SI; Katai H; Kinoshita T; Shibata T; Kohno T; Kanai Y
Carcinogenesis; 2017 Mar; 38(3):241-251. PubMed ID: 28069692
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.
Sato T; Arai E; Kohno T; Tsuta K; Watanabe S; Soejima K; Betsuyaku T; Kanai Y
PLoS One; 2013; 8(3):e59444. PubMed ID: 23544068
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.
Yamanoi K; Arai E; Tian Y; Takahashi Y; Miyata S; Sasaki H; Chiwaki F; Ichikawa H; Sakamoto H; Kushima R; Katai H; Yoshida T; Sakamoto M; Kanai Y
Carcinogenesis; 2015 May; 36(5):509-20. PubMed ID: 25740824
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status.
Arai E; Kanai Y
Epigenomics; 2010 Jun; 2(3):467-81. PubMed ID: 22121905
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma.
Arai E; Ushijima S; Gotoh M; Ojima H; Kosuge T; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Hirohashi S; Kanai Y
Int J Cancer; 2009 Dec; 125(12):2854-62. PubMed ID: 19569176
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis.
Kuramoto J; Arai E; Tian Y; Funahashi N; Hiramoto M; Nammo T; Nozaki Y; Takahashi Y; Ito N; Shibuya A; Ojima H; Sukeda A; Seki Y; Kasama K; Yasuda K; Kanai Y
Carcinogenesis; 2017 Mar; 38(3):261-270. PubMed ID: 28426876
[TBL] [Abstract][Full Text] [Related]
7. DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of 'pan-negative'-type lung adenocarcinomas.
Hamada K; Tian Y; Fujimoto M; Takahashi Y; Kohno T; Tsuta K; Watanabe SI; Yoshida T; Asamura H; Kanai Y; Arai E
Carcinogenesis; 2021 Feb; 42(2):169-179. PubMed ID: 33152763
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia.
Waki T; Tamura G; Tsuchiya T; Sato K; Nishizuka S; Motoyama T
Am J Pathol; 2002 Aug; 161(2):399-403. PubMed ID: 12163364
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenetic risk estimation based on quantification of DNA methylation levels in liver tissue at the precancerous stage.
Nagashio R; Arai E; Ojima H; Kosuge T; Kondo Y; Kanai Y
Int J Cancer; 2011 Sep; 129(5):1170-9. PubMed ID: 21400512
[TBL] [Abstract][Full Text] [Related]
11. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
[TBL] [Abstract][Full Text] [Related]
12. Methylated genes as new cancer biomarkers.
Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
[TBL] [Abstract][Full Text] [Related]
13. CpG island methylation in premalignant stages of gastric carcinoma.
Kang GH; Shim YH; Jung HY; Kim WH; Ro JY; Rhyu MG
Cancer Res; 2001 Apr; 61(7):2847-51. PubMed ID: 11306456
[TBL] [Abstract][Full Text] [Related]
14. Changes of bivalent chromatin coincide with increased expression of developmental genes in cancer.
Bernhart SH; Kretzmer H; Holdt LM; Jühling F; Ammerpohl O; Bergmann AK; Northoff BH; Doose G; Siebert R; Stadler PF; Hoffmann S
Sci Rep; 2016 Nov; 6():37393. PubMed ID: 27876760
[TBL] [Abstract][Full Text] [Related]
15. Alterations of DNA methylation and clinicopathological diversity of human cancers.
Kanai Y
Pathol Int; 2008 Sep; 58(9):544-58. PubMed ID: 18801069
[TBL] [Abstract][Full Text] [Related]
16. Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.
Arai E; Chiku S; Mori T; Gotoh M; Nakagawa T; Fujimoto H; Kanai Y
Carcinogenesis; 2012 Aug; 33(8):1487-93. PubMed ID: 22610075
[TBL] [Abstract][Full Text] [Related]
17. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection.
Park SY; Yoo EJ; Cho NY; Kim N; Kang GH
J Pathol; 2009 Dec; 219(4):410-6. PubMed ID: 19639607
[TBL] [Abstract][Full Text] [Related]
18. Methylation profiles of CpG island loci in major types of human cancers.
Park SY; Kim BH; Kim JH; Cho NY; Choi M; Yu EJ; Lee S; Kang GH
J Korean Med Sci; 2007 Apr; 22(2):311-7. PubMed ID: 17449942
[TBL] [Abstract][Full Text] [Related]
19. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
[TBL] [Abstract][Full Text] [Related]
20. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state.
Kanai Y; Hirohashi S
Carcinogenesis; 2007 Dec; 28(12):2434-42. PubMed ID: 17893234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
